📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Genetic variants in PPARGC1B and CNTN4 are associated with thromboxane A2 formation and with cardiovascular event free survival in the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). (2018)

First Author: McCarthy NS

Attributed to: Centre for Health service and Academic Partnership in Translational eHealth Research (CHAPTER) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.atherosclerosis.2017.12.013

PubMed Identifier: 29258006

Publication URI: http://europepmc.org/abstract/MED/29258006

Type: Journal Article/Review

Volume: 269

Parent Publication: Atherosclerosis

ISSN: 0021-9150